MoneyWorks4Me

Ajanta Pharma inform about disclosure

16 Sep 2025 Evaluate

Ajanta Pharma has informed that it enclosed disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 16, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1861.75
Dr. Reddys Labs. 1172.60
Cipla 1379.35
Lupin 2079.45
Zydus Lifesciences 1137.05
View more..